Research

A Conversation with Neurogene's Leadership

Neurogene Advances a Rett Gene Replacement Program that Got Its Start at RSRT

MECP2 Reactivation: Why Do Some Genes Reactivate While Others Don't?

Taysha Gene Therapies Shares Rett Syndrome Community Statement on its Clinical Trial

Bluntness: How You Can Speed the Research, and Why You Should

How Families and the Rett Syndrome Global Registry Will Help Cure Rett

How RSRT is driving the search for a Rett cure

The Rett Syndrome Research Trust Biorepository Spurs Drug Development Efforts

Monica’s Perspective on the Novartis News

Novartis Terminates Their Rett Syndrome Gene Replacement Program

Outcomes of a Marathon FDA Meeting on the Safety of Gene Replacement

Taysha Gene Therapies Shares Letter to the Rett Syndrome Community

Taysha Gene Therapies Announces Age Range For First Trial During Educational Rett Event for Investors

A Company working on a Rett Curative Therapy is Getting Backed by a Pharmaceutical Powerhouse

News from Taysha That We are One Step Closer to Testing Gene Replacement for Rett

A Reason to Celebrate: Children with a Severe Neurological Disorder Improve After Gene Replacement

Biopharma Tool Kit for Rett Syndrome Development Programs

Gene Replacement for Rett Syndrome 101